Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
1st Aug 2019 2:10 pm RNS Total Voting Rights
1st Aug 2019 7:00 am RNS GSK completes transaction with Pfizer for New JV
30th Jul 2019 3:35 pm RNS Director/PDMR Shareholding
29th Jul 2019 7:00 am RNS ViiV submits cabotegravir to EMA for HIV injection
24th Jul 2019 6:01 pm RNS Director/PDMR Shareholding
24th Jul 2019 4:01 pm RNS ViiV 2DR TANGO switch study positive at 48 weeks
24th Jul 2019 4:00 pm RNS ViiV GEMINI studies show high efficacy at 96 weeks
24th Jul 2019 12:07 pm RNS Second Price Monitoring Extn
24th Jul 2019 12:02 pm RNS Price Monitoring Extension
24th Jul 2019 12:00 pm RNS 2nd Quarter Results
24th Jul 2019 10:00 am RNS Non-Executive Chairman
22nd Jul 2019 5:00 pm RNS ViiV presents 96-week data from phase III study
15th Jul 2019 6:19 pm RNS Director/PDMR Shareholding
15th Jul 2019 6:18 pm RNS Director/PDMR Shareholding
15th Jul 2019 6:16 pm RNS Director/PDMR Shareholding
15th Jul 2019 11:42 am RNS Director/PDMR Shareholding
15th Jul 2019 7:00 am RNS positive results in Phase 3 PRIMA study of ZEJULA
12th Jul 2019 4:35 pm RNS Director/PDMR Shareholding
12th Jul 2019 3:55 pm RNS Director/PDMR Shareholding
10th Jul 2019 3:48 pm RNS Director/PDMR Shareholding
10th Jul 2019 7:00 am RNS ViiV switch study shows 2DR as effective as 3DR
1st Jul 2019 12:08 pm RNS Total Voting Rights
12th Jun 2019 5:10 pm RNS Director/PDMR Shareholding
7th Jun 2019 7:00 am RNS FDA approval for Nucala self-administration
4th Jun 2019 8:00 am RNS CHMP positive on GSK's Nucala self-administration
3rd Jun 2019 2:31 pm RNS Total Voting Rights
24th May 2019 10:54 am RNS Director/PDMR Shareholding
20th May 2019 1:44 pm RNS Director/PDMR Shareholding
13th May 2019 5:44 pm RNS Block listing Interim Review
13th May 2019 4:19 pm RNS Director/PDMR Shareholding
8th May 2019 6:23 pm RNS Result of AGM & GM
2nd May 2019 5:07 pm RNS Trelegy Ellipta asthma study met primary endpoint
1st May 2019 3:11 pm RNS Director/PDMR Shareholding
1st May 2019 2:32 pm RNS Total Voting Rights
1st May 2019 12:00 pm RNS 1st Quarter Results
29th Apr 2019 12:00 pm RNS ViiV submits NDA for HIV monthly 2 drug injectable
26th Apr 2019 4:16 pm RNS ViiV receives CHMP Positive Opinion for Dovato
16th Apr 2019 5:36 pm RNS Director/PDMR Shareholding
16th Apr 2019 5:35 pm RNS Director/PDMR Shareholding
16th Apr 2019 5:23 pm RNS Director/PDMR Shareholding
FTSE 100 Latest
Value8,632.33
Change89.77